Vistogard
(uridine triacetate)Wellstat Therapeutics Corporation
Usage: VISTOGARD® is indicated for the emergency treatment of adults and pediatric patients after a fluorouracil or capecitabine overdose, or those experiencing severe toxicity or adverse reactions within 96 hours post-administration. It is not recommended for non-emergency use, as it may reduce the efficacy of these drugs.